Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. (Q37400592)
Jump to navigation
Jump to search
scientific article published on 08 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. |
scientific article published on 08 September 2009 |
Statements
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker (English)
P N Munster
D Marchion
S Thomas
M Egorin
S Minton
G Springett
J-H Lee
G Simon
A Chiappori
8 September 2009
1 reference
1 reference
1 reference
1 reference
1 reference